Delivered as a Hybrid Event April 2023
April 25 - 27, 2023keyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
LIVE: DAY 2 ✦ Tues, Apr 26 - EDT
search
LIVE: DAY 2 ✦ Tues, Apr 26 - EDT
search
8:00am - 8:30am30 mins
Industry-Only Solution Summit Hosted by Lextegrity
- Verity Blair - Enterprise Account Executive, Lextegrity
- Parth Chanda - CEO and Founder, Lextegrity
8:30am - 8:45am15 mins
Chairperson’s Review of Day One
- John Oroho - Executive Vice President, Chief Strategy Officer, Porzio Life Sciences, LLC
8:45am - 9:15am30 mins
Compliance Top 10 — Clear and Concise Overview of the Top Areas of Concern for the Compliance Professional
- John Oroho - Executive Vice President, Chief Strategy Officer, Porzio Life Sciences, LLC
9:15am - 10:15am60 mins
CCO Innovation Panel
- Justin Will - Global Commercial Compliance Consulting and Managed Services Practice Leader, IQVIA
- Cynthia Cetani - Chief Integrity & Compliance Officer, Indivior
- David Ryan - Vice President, Chief Compliance Officer, Epizyme
- Gregory Moss - Executive Vice President, General Counsel, Kadmon, a Sanofi Company, Former Chief Compliance Officer of Kadmon
- Daryl Kreml - Chief Compliance Officer, Sage Therapeutics
10:15am - 10:45am30 mins
Networking Break
10:45am - 11:30am45 mins
Risk Insights and Monitoring – An Enforcer's Landscape
- Tim Robinson, Esq. - Chief Legal and Privacy Officer, MediSpend
- Seth Houston - Chief Commercial Officer, MediSpend
11:30am - 12:30pm60 mins
Former Prosecutor Spotlight
- Rachael Honig - Former Acting U.S. Attorney, U.S. Attorney's Office for the District of New Jersey
- George Varghese - Partner, WilmerHale LLP
- Nathaniel Mendell - Former, Acting U.S. Attorney, U.S. Attorney’s Office for the District of Boston; Partner, Morrison & Foerster LLP
- Ernie Hernandez - Vice President, Chief Compliance Officer, Global Blood Therapeutics
12:30pm - 1:30pm60 mins
Networking Luncheon
Attendees Choose From Three Breakouts
1:30pm - 2:15pm45 mins
Breakout 1
Operationalizing the OIG Special Fraud Alert on Speaker Programs
- Marci Juneau - Partner, Helio Health Group
- Hannah Putnam - Senior Ethics & Compliance Officer, Fresenius Medical Care North America
- Daina Selvig - Vice President, Legal & Chief Compliance Officer, Ardelyx
- Sarah Whipple - VP, Legal and Chief Compliance Officer, Akebia Therapeutics, Inc.
- Andrea Kocharyan - Vice President, Head of Legal & Compliance, Zealand Pharma US
- Ernie Hernandez - Vice President, Chief Compliance Officer, Global Blood Therapeutics
- Averi Price - Former SVP, General Counsel and Chief Compliance Officer, Radius Health
1:30pm - 2:15pm45 mins
Breakout 2
Clinical and R&D Trends
- Meena Datta - Partner, Sidley Austin LLP
1:30pm - 2:15pm45 mins
Breakout 3
Conducting Risk Mapping and a Risk Assessment
- Tara D’Orsi - Executive Vice President, Chief Compliance Officer and General Counsel, Kyowa Kirin North America
- Regina Alvarado - Principal, Strategy, Life Sciences, US Compliance Consulting Lead, IQVIA
- Maria Ostrovsky - Chief Compliance Officer, Associate General Counsel, Deciphera Pharmaceuticals
- Heather Golding - Former General Counsel and Chief Ethics & Compliance Officer, Sobi North America
Attendees Choose From Three Breakouts
2:15pm - 3:00pm45 mins
Breakout 1
Drug Pricing and State Transparency Updates
- Katherine Chaurette - Senior Vice President, Healthcare Law and Compliance, Blueprint Medicines
- Chris Sloan - Associate Director, Market Access Marketing, Blueprint Medicines
2:15pm - 3:00pm45 mins
Breakout 2
Global Compliance Training Considerations and Trends
- Richard Hodgins - Chief Technology Officer, Intuition
- Melanie Polloway - Executive Director, Compliance, Daiichi Sankyo, Inc.
- Daniel Font - Director, Compliance Investigations and Privacy, Daiichi Sankyo Inc.
2:15pm - 3:00pm45 mins
Breakout 3
A Look at Commercial and Medical Affairs to Understand Changes to An Organization’s Evolving Compliance Needs
- David Ryan - Vice President, Chief Compliance Officer, Epizyme
- Jake DeBoever - Vice President, Chief Compliance Officer, Dermavant Sciences
- Amy Wilson - Vice President, Chief Compliance Officer, Esperion
- Ed Sleeper - Global Ethics and Compliance Officer, HUTCHMED International Corporation
- Joy Dowdle - Partner, Life Sciences & Healthcare Practice, Paul Hastings
3:00pm - 3:30pm30 mins
Networking Break
Attendees Choose From Three Breakouts
3:30pm - 4:15pm45 mins
Breakout 1
From the Ground Up—Building & Implementing a Privacy Management Strategy
- Kris Hall, JD, CIPP/CIPM - Managing Director, Dovetail Consulting Group
- Raegan McClain - Chief Compliance Officer, Oyster Point
3:30pm - 4:15pm45 mins
Breakout 3
Advertising, Promotion and Communication Strategies for Biologics, Biosimilars, and Interchangeable Biosimilars
- Craig Bleifer - Partner, Akin, Gump Strauss, Hauer & Feld LLP
- Timothy Roberts - Vice President, Chief Compliance Officer, Amneal Pharmaceuticals
4:15pm - 5:00pm45 mins
Breakout 1
Reduce Compliance Risk Using a Continuous Learning Approach
- Daniel O’Connor - Senior Vice President, PharmaCertify
- Ed Sleeper - Global Ethics and Compliance Officer, HUTCHMED International Corporation
- Dhara Moro - Associate Director, Compliance Operations, Sage Therapeutics
- Jennifer Garon - Senior Manager, Global Compliance Operations, Sarepta Therapeutics
4:15pm - 5:00pm45 mins
Breakout 2
Break Down the Silo: How to Integrate your Total Business Risk during M&A
- Anthony Greco - Director, Pharmaceutical & Life Sciences; Risk & Regulatory Consulting Services, PwC
- Laurel Saltiel - Manager, Pharmaceutical & Life Sciences; Risk & Regulatory Consulting Services, PwC